Literature DB >> 12490073

Mice with a mutation in the thyroid hormone receptor beta gene spontaneously develop thyroid carcinoma: a mouse model of thyroid carcinogenesis.

Hideyo Suzuki1, Mark C Willingham, Sheue-Yann Cheng.   

Abstract

The molecular genetic basis of thyroid carcinogenesis is not well understood. Most of the existing models of thyroid cancer only rarely show metastases, and this has limited progress in the understanding of the molecular events in thyroid cancer invasion and metastasis. We have recently generated a mutant mouse by introducing a dominant negative mutant thyroid hormone nuclear receptor gene, TRbetaPV, into the TRbeta gene locus. In this TRbetaPV mouse, the regulation of the thyroid-pituitary axis is disrupted, leading to a mouse with high levels of circulating thyroid-stimulating hormone and extensive hyperplasia of follicular epithelium within the thyroid. As TRbeta(PV/PV) mice, but not TRbeta(PV/+) mice, aged, metastatic thyroid carcinoma developed. Histologic evaluation of thyroids of 5-14-month-old mice showed capsular invasion (91%), vascular invasion (74%), anaplasia (35%), and metastasis to the lung and heart (30%). Previous models of thyroid cancer have focused on genes that control initial carcinogenesis, but this model provides an unusual opportunity to study the alterations in gene regulation that occur with clinically relevant changes during progression and metastasis in a predictable fashion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12490073     DOI: 10.1089/105072502320908295

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  98 in total

Review 1.  Thyroid hormone receptors and cancer.

Authors:  Won Gu Kim; Sheue-yann Cheng
Journal:  Biochim Biophys Acta       Date:  2012-04-06

2.  Thyroid Hormone Receptor Beta Induces a Tumor-Suppressive Program in Anaplastic Thyroid Cancer.

Authors:  Eric L Bolf; Noelle E Gillis; Cole D Davidson; Princess D Rodriguez; Lauren Cozzens; Jennifer A Tomczak; Seth Frietze; Frances E Carr
Journal:  Mol Cancer Res       Date:  2020-06-17       Impact factor: 5.852

3.  Impaired adipogenesis caused by a mutated thyroid hormone alpha1 receptor.

Authors:  Hao Ying; Osamu Araki; Fumihiko Furuya; Yasuhito Kato; Sheue-Yann Cheng
Journal:  Mol Cell Biol       Date:  2007-01-12       Impact factor: 4.272

4.  Is serum TSH a biomarker of thyroid carcinoma in patients residing in a mildly iodine-deficient area?

Authors:  Kristine Zøylner Swan; Viveque Egsgaard Nielsen; Christian Godballe; Jens Faunø Thrane; Marie Riis Mortensen; Sten Schytte; Henrik Baymler Pedersen; Peer Christiansen; Steen Joop Bonnema
Journal:  Endocrine       Date:  2018-05-31       Impact factor: 3.633

5.  Expression of stanniocalcin 1 in thyroid side population cells and thyroid cancer cells.

Authors:  Suguru Hayase; Yoshihito Sasaki; Tsutomu Matsubara; Daekwan Seo; Masaaki Miyakoshi; Tsubasa Murata; Takashi Ozaki; Kennichi Kakudo; Kensuke Kumamoto; Kris Ylaya; Sheue-yann Cheng; Snorri S Thorgeirsson; Stephen M Hewitt; Jerrold M Ward; Shioko Kimura
Journal:  Thyroid       Date:  2015-03-23       Impact factor: 6.568

Review 6.  Lessons from mouse models of thyroid cancer.

Authors:  Caroline S Kim; Xuguang Zhu
Journal:  Thyroid       Date:  2009-12       Impact factor: 6.568

7.  The cytoplasmic domain of proEGF negatively regulates motility and elastinolytic activity in thyroid carcinoma cells.

Authors:  Aleksandra Glogowska; Janette Pyka; Astrid Kehlen; Marek Los; Paul Perumal; Ekkehard Weber; Sheue-yann Cheng; Cuong Hoang-Vu; Thomas Klonisch
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

8.  PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer.

Authors:  C J Guigon; L Zhao; M C Willingham; S-Y Cheng
Journal:  Oncogene       Date:  2008-11-10       Impact factor: 9.867

Review 9.  Molecular pathogenesis and mechanisms of thyroid cancer.

Authors:  Mingzhao Xing
Journal:  Nat Rev Cancer       Date:  2013-03       Impact factor: 60.716

Review 10.  Molecular aspects of thyroid hormone actions.

Authors:  Sheue-Yann Cheng; Jack L Leonard; Paul J Davis
Journal:  Endocr Rev       Date:  2010-01-05       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.